Evidence‑Based Management of Acute Mastoiditis
Initial Management of Uncomplicated Cases
- For patients with acute mastoiditis who have no neurologic deficits, sepsis, or subperiosteal abscess, start intravenous antibiotics ± myringotomy; reserve mastoidectomy for those who do not improve after 48 hours or who clinically deteriorate. – American Academy of Otolaryngology‑Head and Neck Surgery 1
- In uncomplicated presentations, postpone CT scanning until clinical reassessment; imaging is not required at presentation. – American Academy of Otolaryngology‑Head and Neck Surgery 1
- Reassess at 48 hours: if there is no improvement or worsening, obtain a CT scan to evaluate for intracranial complications and proceed to mastoidectomy as indicated. – American Academy of Otolaryngology‑Head and Neck Surgery 1
Management of Subperiosteal Abscess (SPA)
- In children with SPA, needle aspiration plus myringotomy (with or without tube insertion) successfully treated 57 % of cases without the need for mastoidectomy (Greek cohort). – American Academy of Otolaryngology‑Head and Neck Surgery 1
Intracranial and Vascular Complications
- Immediate CT imaging is mandated for any suspected intracranial complication of acute mastoiditis. – American Academy of Otolaryngology‑Head and Neck Surgery 1
- Brain abscess is identified as the most common intracranial complication of acute mastoiditis. – American Academy of Otolaryngology‑Head and Neck Surgery 1
- For sigmoid sinus thrombosis, treat with intravenous antibiotics plus anticoagulation (unless contraindicated). – American Academy of Otolaryngology‑Head and Neck Surgery 1
- Anticoagulation in sigmoid sinus thrombosis achieved 84 % partial or complete recanalization, although supporting evidence is limited. – American Academy of Otolaryngology‑Head and Neck Surgery 1
Antibiotic Therapy
- High‑dose amoxicillin‑clavulanate (80–90 mg/kg/day of the amoxicillin component) is recommended for oral therapy when stepping down from IV treatment. – American Academy of Otolaryngology‑Head and Neck Surgery 2
Surgical Intervention Rates and Outcomes
- Reported mastoidectomy rates vary widely (29 %–93 %), reflecting practice variation rather than disease severity. – American Academy of Otolaryngology‑Head and Neck Surgery 1
- In a Swedish series, 22 % of acute mastoiditis patients required mastoidectomy; 10 % were cured with antibiotics alone and 68 % with antibiotics plus myringotomy. – American Academy of Otolaryngology‑Head and Neck Surgery 1
Critical Clinical Pitfalls
- 33 %–81 % of patients presenting with acute mastoiditis had received prior antibiotics, underscoring that antecedent therapy does not eliminate the risk of mastoiditis. – American Academy of Otolaryngology‑Head and Neck Surgery 1
- No reliable clinical signs can differentiate patients with versus without intracranial involvement; imaging is essential when suspicion exists. – American Academy of Otolaryngology‑Head and Neck Surgery 1
- Failure to improve after 48 hours of appropriate medical therapy mandates CT scanning to assess for complications. – American Academy of Otolaryngology‑Head and Neck Surgery 1
- Cases with bony erosion or coalescence should be excluded from the “uncomplicated” category to ensure appropriate conservative management. – American Academy of Otolaryngology‑Head and Neck Surgery 1
Oral Antibiotic Step‑Down Therapy for Pediatric Acute Mastoiditis
Recommended High‑Dose Regimen
- Amoxicillin‑clavulanate (amoxicillin component 90 mg/kg/day, divided twice daily) is advised as the primary oral step‑down after successful intravenous therapy in children with acute mastoiditis. 3
Alternative Regimens for Penicillin‑Allergic Patients
- Cefdinir 14 mg/kg/day (given once or twice daily) can be used when penicillin allergy precludes amoxicillin‑clavulanate. 3
- Cefuroxime 30 mg/kg/day (administered in two divided doses) is an acceptable alternative for penicillin‑allergic children. 3
- Cefpodoxime 10 mg/kg/day (given twice daily) serves as another viable oral option in the setting of penicillin allergy. 3
Cross‑Reactivity Considerations
- Cefdinir, cefuroxime, cefpodoxime, and ceftriaxone exhibit negligible cross‑reactivity with penicillin allergy because of their distinct chemical structures, supporting their safe use in allergic patients. 3